Neoprobe gets clearance for FlowGuard

Radiopharmaceutical firm Neoprobe's subsidiary Biosonix has received Food and Drug Administration clearance for its FlowGuard blood-flow evaluation product. FlowGuard, which received CE mark clearance from European regulatory agencies in late 2001, has been cleared in the U.S. for use in determination of blood flow in non-invasive diagnostic and intraoperative applications, according to Neoprobe of Dublin, OH.

By AuntMinnie.com staff writers
February 28, 2002

Related Reading

Neoprobe reports second year of profitability, February 25, 2002

Neoprobe closes Biosonix purchase, January 4, 2002

Neoprobe moves closer to Biosonix purchase, December 11, 2001

Biosonix gets CE mark for FlowGuard, October 4, 2001

Neoprobe to buy Biosonix, September 7, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 3617
Next Page